Short‐term administration of oclacitinib with concomitant medications in canine epitheliotropic lymphoma: A retrospective study of eight dogs
These results suggest that oral oclacitinib has limited efficacy in the treatment of canine CEL. Larger prospective studies are recommended to further investigate the optimal dose, treatment duration and potential combination therapies involving oclacitinib.
Authors
- Takafumi Osumi (ORCID: https://orcid.org/0000-0001-9819-8673)
- Yusuke BABA
- A. Teh (ORCID: https://orcid.org/0000-0002-6867-7670)
- Toshiaki Asakura (ORCID: https://orcid.org/0000-0001-8838-785X)
- Sadako OBAYASHI
- Ikki Mitsui (ORCID: https://orcid.org/0000-0002-6108-0097)
- Shinya Morikawa
- Mary Otsuka (ORCID: https://orcid.org/0000-0001-8870-3875)
- Miyuki Yamada
Institutions
- IDEXX Laboratories (France) (FR)
- Kamiichi General Hospital (JP)
- The Polytechnic University of Japan (JP)
- Veterinary Medical Center (JP)
- Shibuya (Japan) (JP)
- Fujita Animal Hospital (JP)
- Kokura Memorial Hospital (JP)
- Chiba Institute of Technology (JP)
Publication Details
- Journal
- Veterinary Dermatology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1111/vde.13366
- Citations
- 2
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04